step 6: how does usfda review an investigational new drug (ind) application? | regulatory learnings
Published 2 years ago • 434 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
3:13
step 6: how does usfda review an investigational new drug (ind) application (part 2)? | dra
-
5:30
what is investigational new drug (ind) application? | regulatory learnings | drug regulatory affairs
-
3:59
step 5: how to submit an investigational new drug (ind) application to usfda? | regulatory learnings
-
4:25
step-wise approach for investigational new drug (ind) application? | regulatory learnings | dra
-
46:00
introduction to investigational new drug (ind) applications (3/14) redi 2017
-
4:42
step 7: how are clinical trials registered in usa? | regulatory learnings
-
6:43
step 4: types of usfda forms for ind application (part 2)? | regulatory learnings | dra
-
20:26
export to usa: how to easily get an fda license (a complete guide for food exporters)
-
1:00:47
understanding new drug applications (ndas)
-
40:53
submit your investigational new drug (ind) application and clinical holds (9/14) redi 2017
-
3:17
how does the fda approve new drugs?
-
5:32
step 9: completion of clinical trial and ending an ind | regulatory learnings | dra
-
3:25
how to register an investigational new drug (ind) to the us fda
-
8:17
step 4: what content do we include in ind application (part 1)? | regulatory learnings | dra
-
4:15
step 8: how to do ind life cycle management? | regulatory learnings| dra
-
3:17
how does the fda approve new drugs?
-
1:20
investigational new drug (ind) for us fda | phase 1 to 4 clinical trials services | drug development
-
8:11
regulatory shorts#1 | covid-19 vaccine | expanded access vs emergency use authorization vs off-label
-
3:54
the four phases of clinical trials | diversity in clinical trials | akf
-
40:34
demystifying the investigational new drug (ind) application for drugs and biologics (3of14) redi '18
-
6:25
regulatory shorts#6 | global expedited regulatory pathways | drug regulatory affairs